Source: School Course 2014 - Interstitial lung diseases
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Behr (Munich, Germany). Pulmonary Hypertension and cardiovascular disease in ILDs. School Course 2014 - Interstitial lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension and cardiovascular diseases in ILD Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Pulmonary hypertension and cardiovascular diseases in ILD Source: ERS Course 2016 Year: 2016 HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Pulmonary hypertension due to lung disease Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Pulmonary Hypertension and IPF? Source: Virtual Congress 2021 – Pulmonary hypertension and interstitial pulmonary fibrosis Year: 2021 Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Cardiovascular disease in COPD Source: Eur Respir Monogr 2020; 88: 47-65 Year: 2020 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary hypertension due to lung disease – Results from COMPERA Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Characteristics of patients with pulmonary hypertension in end stage renal disease Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014